Performa HargaHarga kembali 1 minggu4.11%
Harga kembali 1 Bulan0.18%
Harga kembali 3 Bulan26.79%
Harga kembali 6 Bulan5.72%
Harga Tertinggi (52 Minggu)78.46
Harga Terendah (52 Minggu)44.31
Latar Belakang Perusahaan
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
Summary
Valuation Information
Current PE Ratio (TTM)-9.12
Forward PE Ratio23.36
Current Price to Book Value2.99
Current Price to Sales1280.22
EV to Revenue3754.61
EV to EBITDA14.16
PEG Ratio-
Per Share
Current EPS (Annualized)-6.17
Diluted EPS (TTM)-6.17
Revenue Per Share0.04
Current Book Value Per Share18.83
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-531080000
Profit Margin0
Operating Margin-89.33
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
